Krishana Phoschem share price today

Krishana Phoschem Ltd's share price was ₹243.79 at the close on 6 November 2026. It has been rising for 80 weeks. That is 55.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹94 and ₹245, and at that close it sat 99% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Krishana Phoschem Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 20 weeks in a row.

Over the last 9.7 years the share price moved +6,846% while the NIFTY 500 moved +184%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: revenue up on a year earlier for 11 quarters in a row (every quarter we can compare), profit up on a year earlier for 7 quarters in a row and foreign funds (FIIs) raised their stake for 3 quarters in a row.

1. Revenue up on a year earlier for 11 quarters in a row (every quarter we can compare)

   In the June 2026 quarter revenue was ₹532 crore, +34.3% on a year earlier.

2. Profit up on a year earlier for 7 quarters in a row

   In the June 2026 quarter profit was ₹47 crore, +51.6% on a year earlier.

3. Foreign funds (FIIs) raised their stake for 3 quarters in a row

   From 0.2% to 0.6% of the company by the September 2026 quarter.

For April to June 2026 (the quarter ended 30 June 2026), Krishana Phoschem reported revenue of ₹532 crore, up 34.3% from ₹396 crore a year earlier, and a profit of ₹47.0 crore, up 51.6% from ₹31.0 crore.

Krishana Phoschem results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

The newest call in our records is from 9 April 2026, about January to March 2026; a call about these results is not in our records yet.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Krishana Phoschem closed at ₹243.79 on 6 November 2026, up 140.0% from ₹101.56 a year earlier (7 November 2025) and up 1,356.3% over five years. Its highest weekly close since March 2017 was ₹243.79 on 6 November 2026.

Krishana Phoschem share price: then and now

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 6 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

500 weekly closes from 3 March 2017 to 6 November 2026.

6 Nov 2026: Krishana Phoschem closed at ₹243.79, up 6.7% on the week and up 23.7% on the month. Our read, 10 Oct 2026: Commissioned capacity supports further sales, but debt-funded receivables and tax-assisted earnings prevent treating the expansion as a proven cash-return story.

Earlier

• 3 Jul 2026: Share split: face value cut from ₹10 to ₹2 a share (ex-date).
• Results for April to June 2026: Revenue up 34.3% and profit up 51.6% on a year earlier.
• 17 Jun 2026: ex-date for a dividend of ₹0.50 a share.
• 9 Apr 2026: Krishana Phoschem held its results call for January to March 2026.

Our read of the business

April to June 2026: Operating growth continues, but financing absorbs part of the benefit.

Our read after the April to June 2026 results, written 10 October 2026.

Krishana Phoschem paid ₹0.10 a share in regular dividends in the 12 months to 7 November 2026 (1 payment), a yield of 0.04% at the ₹243.79 close on 6 November 2026. The last was a dividend of ₹0.50 a share, ex-date 17 June 2026.

Krishana Phoschem dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 1 of the last 12 months' payments came before a split or bonus; the 12-month total above is on today’s share count.

Yes. Krishana Phoschem Ltd paid out 2% of its profit as dividends in FY26, and it paid a dividend in 7 of its last 13 reported years.

From the NSE corporate-actions record, read 7 November 2026.

On the call for January to March 2026, held on 9 April 2026, Krishana Phoschem's management spoke about the quarter; the main points are below.

“The 140 crore population of India needs to be fed. Unlike consumer items, you cannot compromise on agricultural output. Farmers must produce, and they need fertilizers. Domestically manufactured products will not face demand pressure. Even if demand were to drop hypothetically, India imports almost 40% of its fertilizer requirements. …”Praveen Oswal, Managing Director, on the call for January to March 2026

Source: the call transcript.

From the call for January to March 2026, 9 April 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.

The changes showing up in Krishana Phoschem's own numbers are costs spread over more sales. It is too early to say whether they last.

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Checked against results and calls up to January to March 2026, 10 October 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.

The thesis breaks if the completed expansion produces more sales while operating cash remains negative and borrowings continue rising after the promised receivable collection window.

Each change stops working if

• Manufacturing capacity ramp: New manufacturing capacity remains underused after the guided ramp window, or incremental output requires financing that absorbs its profit contribution.
• Pricing and subsidy offset: Feedstock inflation exceeds realized price and subsidy offsets, or collections lag the cash cost of production.
• Integrated manufacturing inputs: Purchased feedstock and operating costs erase the integrated production advantage.
• Receivable collection: Collections are delayed or replaced by another receivable build as sales expand.

The main risks

• Tax-assisted earnings and peak returns: The March profit spike contains a non-repeatable estimated tax contribution. ⚠ estimate
• Feedstock pass-through failure: Pricing and subsidy offsets may arrive after input costs must be paid. ⚠ estimate
• Guidance and disclosure reliability: Cross-call assurances changed on trading, margins and working capital. ⚠ estimate
• Per-share and source reconciliation: Summary EPS, financial cells and call labels contain unresolved inconsistencies. ⚠ estimate

Our read after the April to June 2026 results, written 10 October 2026.

When Krishana Phoschem reports July to September 2026, these are the check that show whether the story is still on course. First: September 2026 quarter revenue above ₹608 crore (the year-earlier figure) with operating margin at or above 12% and operating profit growth outrunning the rise in depreciation plus interest (₹14 crore and ₹21 crore in June 2026).

Krishana Phoschem is on 2 of our India lists: Momentum stocks and 52 week high & low.

Krishana Phoschem Ltd earned ₹47.0 Cr of net profit in the Jun 2026 quarter, +51.6% on the same quarter a year earlier. That is the 7th quarter in a row of profit growth. Full-year FY26 profit was ₹180 Cr. Over 10 years profit has grown 68.1% a year on average. That is 8.8% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹31.0 Cr.

For the full year, FY26 profit was ₹180 Cr (+106.9% on the year before).

Why profit moved: revenue changed +34.3% on a year earlier and the margin moved +0.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +88.6% and revenue +78.2%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

Krishana Phoschem Ltd reported ₹532 Cr of revenue in the Jun 2026 quarter, +34.3% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 10 years it has grown 39.1% a year on average. The last full year, FY26, came in at ₹2,416 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. The mechanism transfers some input inflation to government support and customer pricing. Announcement alone does not establish realization, and farmer affordability can limit what the company keeps. The June operating result is compatible with margin preservation, but the call predates it and does not prove the cause. Competitor pricing response and realized net prices are unknown.

The last four reported quarters add to ₹2,554 Cr.

FY26 revenue was ₹2,416 Cr, +78.3% on the year before.

Recent pace: the last four quarters grew +78.2% on average, against 39.1% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +73.3%, against +56.8% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +92.2%, against +108.7% a year (rolling over).

Krishana Phoschem Ltd's operating margin was 17.0% in the Jun 2026 quarter, about the same as the same quarter a year ago. Across 13 years it has been between 12.0% and 23.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. Management identifies backward integration as a cost advantage. This can retain part of the manufacturing contribution, but it does not remove exposure to purchased ammonia, sulfur or financing. The benefit already embedded in reported manufacturing economics must not be counted again as a new profit stream. Neither comparative unit costs nor the incremental cash saving is supplied.

In the latest quarter it moved +0.0 percentage points on the same quarter a year ago.

Why the margin moved: operating margin changed +0.1 percentage points on the year while gross margin changed −4.6 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years Krishana Phoschem Ltd's operations used more cash than they brought in, so cash conversion was −39%, a gap worth watching. In FY26 its operations used ₹191 Cr of cash, against ₹180 Cr of profit. After ₹112 Cr of spending on assets, free cash was −₹303 Cr: it spent more than its operations brought in.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Why this happened. The April summary identifies subsidy and customer receivables and expects settlement. This is a balance-sheet release opportunity rather than additional earnings. Cash belongs to shareholders only after repayment needs and continuing working-capital demands are met. The promised settlement window has passed, but the bundle has no subsequent cash-flow or receivable disclosure to verify delivery.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why −39% of profit came in as cash: the cash cycle got 32 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. When less than 70% of profit comes in as cash, it is the thing to watch on this page.

What to look at next: the bigger use of cash is spending on new assets, at 1.9× depreciation over three years. The next section checks what that spending is building.

Krishana Phoschem Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 126 days in FY26, down from 158 days in FY21. It spent ₹189 Cr on assets over the last 3 years. Customers take 108 days to pay, and stock sits for 65 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Why this happened. The Capex Inflection Point applies to the reported commissioning and dated utilization ramp. Customers benefit from product availability; shareholders retain a benefit only if manufactured sales generate contribution after feedstock, depreciation, financing and collection costs. Imports used to cover the portfolio are part of this same route to customers, not a separate operating-leverage gain. Competitor capacity and customer substitution are not quantified in the bundle. Reported commissioning is delivered according to the summary; the subsequent utilization and cash contribution remain unverified.

At FY26 sales of ₹2,416 Cr, each day of that cycle ties up about ₹6.6 Cr, so roughly ₹834 Cr is tied up in the business at any time.

FY26: customers took 108 days to pay and stock sat for 65 days, about 2.1 months of sales sitting as stock, for a full cycle of 126 days, shorter than FY21's 158.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 65 days. Customers pay about 108 days after that. Suppliers are paid at 47 days. Together that makes the 126-day cycle.

Spending on assets: ₹189 Cr over the last 3 years, against ₹99.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹1.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Krishana Phoschem Ltd's P/E is 38.4×, near the high end of its own history: higher than 80% of past readings. Its usual P/E (the middle reading) is 28.2×, over 9.7 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.